Case Report on Multiple Issues in Horse with Equine Motor Neuron Disease

Veterinarians and researchers caution that muscle biopsies are important in horses with neuromuscular disease and possible concurrent issues.

Some horses have concurrent diseases that might require specific treatment for a positive outcome for the horse. iStock/Catnap72

A 2020 article published in Equine Veterinary Education discussed the “importance of muscle biopsy in horses with neuromuscular disease as concurrent diseases may be present that require specific treatment for a positive outcome.”

“Sarcocystis myositis and vitamin E deficiency in a Gypsy Vanner stallion suspected of having equine motor neuron disease” was authored by A. C. Trimble, K. M. Delph and E. R. Perry of Kansas State University; and S. J. Valberg of Michigan State University. 

Summary

A 3‐year‐old Gypsy Vanner stallion was presented for evaluation of intermittent recumbency, muscle fasciculations, weakness, low head carriage, shifting of weight between the hindlimbs and an elevated tail head. History, physical examination and serum alpha tocopherol concentrations were suggestive of vitamin E deficiency and equine motor neuron disease (EMND). Sacrocaudalis dorsalis medialis muscle biopsy identified myositis secondary to sarcocystosis. Treatment with alpha tocopherol, ponazuril and sulfadiazine/pyrimethamine resulted in significant improvement in muscle weakness and body condition with resolution of sarcocystosis and inflammation on repeat muscle biopsy. This case illustrates the importance of muscle biopsy in horses with neuromuscular disease as concurrent diseases may be present that require specific treatment for a positive outcome.

equimanagement signup

Partners

aaep media partner
avma plit
weva logo
nzeva logo
iselp logo
aaevt logo
naep logo
epm society partner logo
mexican equine vet association logo